Update of the Israeli Experience With Iodine-131 Metaiodobenzylguanidine Therapy for Patients With Malignant Pheochromocytoma, Paraganglioma, and Other NETs
Tomer Charas(Rambam Health Care Campus), Ron Epelbaum(University of Bern), Rahamim Ben-Yosef(Rambam Health Care Campus), Alison Berniger(Rambam Health Care Campus), R. Bar-Deroma(Technion – Israel Institute of Technology)
International Journal of Radiation Oncology*Biology*Physics
October 17, 2015
Cited by 0
Related Papers
Curcumin as an Anti-Cancer Agent: Review of the Gap Between Basic and Clinical Applications
|Current Medicinal Chemistry|2009|480
Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers
|British Journal of Cancer|2014|444
<sup>18</sup>F-FDG Avidity in Lymphoma Readdressed: A Study of 766 Patients
|Journal of Nuclear Medicine|2009|381
Curcumin and Gemcitabine in Patients With Advanced Pancreatic Cancer
|Nutrition and Cancer|2010|279